Literature DB >> 8055446

Conservative surgery for giant cell tumors of the sacrum. The role of cryosurgery as a supplement to curettage and partial excision.

R C Marcove1, D S Sheth, E W Brien, A G Huvos, J H Healey.   

Abstract

BACKGROUND: Giant cell tumors (GCTs) of the sacrum are a difficult clinical problem. Wide excision (total sacrectomy) is associated with high morbidity and pelvic/spinal instability. Curettage with or without supplemental radiotherapy is associated with a high recurrence rate. In view of the proven effectiveness of cryosurgery as an adjunct to curettage for extremity GCT, cryosurgery was used for treatment of GCTs of the sacrum.
METHODS: Seven patients with GCTs of the sacrum were treated at our institution by conservative surgery from 1973 to 1992. Four patients presented with recurrent tumors after failing previous radiation treatment (dose, 5040 cGy). Four patients were treated with curettage with cryosurgery and three with limited excision with cryosurgery. In the latter procedure after limited excision of the caudal (below S2) part of the tumor, the upper sacral segments were treated with curettage and cryosurgery. This spared the important upper sacral roots and maintained the skeletal integrity.
RESULTS: At a median follow-up of 12.25 years (range, 2-14.2 years), all patients were disease free. Local recurrence developed in two patients. Both of these underwent repeat curettage and cryosurgery and have since remained disease free. Two patients had positive second look biopsy with microscopic tumor. Both of these were treated with repeat cryosurgery and have remained disease free. Two patient who developed solitary pulmonary metastases, underwent wedge resection and are alive without disease. No patient suffered neurologic deterioration.
CONCLUSION: Conservative surgery (curettage or partial excision) with adjunct of cryosurgery is our preferred technique for the treatment of GCT of the sacrum. Satisfactory local control could be obtained by close observation, second look biopsy and repeat cryosurgery. The chief advantages of this method include preservation of pelvic and spinal continuity, speed and ease of surgical procedure and less potential blood loss. We recommend it over more radical sacrectomy due to low morbidity and less resultant neurologic deficits.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055446     DOI: 10.1002/1097-0142(19940815)74:4<1253::aid-cncr2820740412>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  24 in total

1.  [Changes in stability after cryosurgical treatment of long tubular bones. An animal experiment study].

Authors:  F Popken; A Niehoff; F Emrich; D Blaecker; M Bosse; J Michael; G-P Brüggemann; P Eysel
Journal:  Unfallchirurg       Date:  2004-02       Impact factor: 1.000

2.  Recurrence after and complications associated with adjuvant treatments for sacral giant cell tumor.

Authors:  Pietro Ruggieri; Andreas F Mavrogenis; Giuseppe Ussia; Andrea Angelini; Panayiotis J Papagelopoulos; Mario Mercuri
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

3.  Conservative surgery in the treatment of giant cell tumor of the sacrum: 35 years' experience.

Authors:  Stepan V Domovitov; Chandhanarat Chandhanayingyong; Patrick J Boland; David G McKeown; John H Healey
Journal:  J Neurosurg Spine       Date:  2015-10-30

4.  Giant cell tumors of the sacrum--a nationwide study on midterm results in 26 patients after intralesional excision.

Authors:  L van der Heijden; M A J van de Sande; I C M van der Geest; H W B Schreuder; B J van Royen; P C Jutte; J A M Bramer; F C Öner; A P van Noort-Suijdendorp; H M Kroon; P D S Dijkstra
Journal:  Eur Spine J       Date:  2014-03-11       Impact factor: 3.134

5.  Giant Cell Tumor of the Sacrum: Series of 19 Patients and Review of the Literature.

Authors:  Khodamorad Jamshidi; Abolfazl Bagherifard; Alireza Mirzaei; Mehrdad Bahrabadi
Journal:  Arch Bone Jt Surg       Date:  2017-11

6.  Zoledronic acid-loaded bone cement as a local adjuvant therapy for giant cell tumor of the sacrum after intralesional curettage.

Authors:  Kun-Hui Chen; Po-Kuei Wu; Cheng-Fong Chen; Wei-Ming Chen
Journal:  Eur Spine J       Date:  2015-05-05       Impact factor: 3.134

Review 7.  The clinical approach toward giant cell tumor of bone.

Authors:  Lizz van der Heijden; P D Sander Dijkstra; Michiel A J van de Sande; Judith R Kroep; Remi A Nout; Carla S P van Rijswijk; Judith V M G Bovée; Pancras C W Hogendoorn; Hans Gelderblom
Journal:  Oncologist       Date:  2014-04-09

8.  Recurrent giant cell tumor of long bones: analysis of surgical management.

Authors:  Frank M Klenke; Doris E Wenger; Carrie Y Inwards; Peter S Rose; Franklin H Sim
Journal:  Clin Orthop Relat Res       Date:  2010-09-16       Impact factor: 4.176

9.  Giant cell tumour of the sacrum: a suggested algorithm for treatment.

Authors:  Rajkumar Thangaraj; R J Grimer; S R Carter; A J Stirling; J Spilsbury; D Spooner
Journal:  Eur Spine J       Date:  2010-01-14       Impact factor: 3.134

10.  Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis.

Authors:  M Lieveld; E Bodson; G De Boeck; B Nouman; A M Cleton-Jansen; E Korsching; M S Benassi; P Picci; G Sys; B Poffyn; N A Athanasou; P C W Hogendoorn; R G Forsyth
Journal:  Virchows Arch       Date:  2014-10-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.